Rheumatoid arthritis patients on medicare seeing increased costs for specialty medications

(Vanderbilt University Medical Center) After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.